Lonsurf Plus Avastin 'Provides Extra Time' for People With Advanced CRC

The recent FDA approval of Lonsurf plus Avastin for metastatic colorectal cancer improves survival and quality of life, an expert said.

Related Keywords

Richard Goldberg ,Marwan Fakih ,Drug Administration ,Virginia University Cancer Institute ,West Virginia University Cancer Institute ,News ,Colorectal Cancer ,